4 Of The Best Income Stocks Around: GlaxoSmithKline plc, Standard Life Plc, SSE PLC And Centrica plc

GlaxoSmithKline plc (LON: GSK), Standard Life Plc (LON: SL), SSE PLC (LON: SSE) and Centrica PLC (LON:CNA) are four of the best dividend plays around.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Standard Life (LSE: SL) has transformed itself into an income champion over the past five years. The company’s shift to a fee-based business model has led to a tripling of cash flow generated from operations since 2010. Assets under management have risen by 50% over the same period. 

This growth has helped support the company’s dividend payout growth. Since 2011 Standard’s dividend payout has increased at a steady rate of 7% per annum. Since 2010 Standard Life has returned 147p per share to investors, including the recent special dividend and over five years the shares have produced a total return of 180%. Based on the estimated growth of the UK pension market, the next five years could see a similar performance. 

Standard Life trades at a forward P/E of 16.8 and supports a yield of 4.6%. Earnings per share are predicted to grow by 48% this year. 

Dividend concerns 

GlaxoSmithKline’s (LSE: GSK) shares have sunk to a four-year low on fears about the sustainability of the company’s dividend payout. However, to a certain extent, these concerns are unfounded.

Management has stated that the company’s dividend of 80p per share is safe for the next three years. A special dividend of 20p per share payable during the fourth quarter will take the total payout for 2015 to 100p per share, a yield of 7.9% based on Glaxo’s current share price. 

Glaxo currently trades at a forward P/E of 16.9 and supports a yield of 7.2%. Earnings per share are predicted to shrink by 21% this year. 

Slow and steady 

Last year, SSE (LSE: SSE) made a commitment to target an increase in the full-year dividend for 2015/16 of at least RPI inflation, with annual increases thereafter of at least RPI inflation also being targeted.

This is hardly the most impressive dividend policy. The RPI measure of inflation has averaged 1% this year, so investors won’t see much in the way of a dividend increase at all. 

Nevertheless, for the conservative dividend investor SSE’s dividend policy is ideal. The payout is covered 1.2 times by earnings per share and due to the nature of SSE’s business, the company has a certain degree of clarity over its revenue streams. As a result, it’s unlikely management will suddenly take an axe to the dividend. 

SSE currently trades at a forward P/E of 12.6 and supports a yield of 6.2%. Earnings per share are predicted to shrink by 10% this year.

Changing business model 

Centrica (LSE: CNA) has already cut its dividend payout once this year. However, according to City projections the new, lower payout is now covered one-and-a-half times by earnings per share, leaving plenty of room for manoeuvre. 

What’s more, management’s recent decision to scale back Centrica’s upstream business is a great move for the company. Oil & gas production is a notoriously volatile and capital intensive business. Focusing on the more predictable customer-facing side of the business should put Centrica back on the path to long-term sustainable growth.

Also, Centrica’s focus on the more predictable customer side of the business should help the company maintain and increase its dividend over time.  

Centrica currently trades at a forward P/E of 12.5 and supports a yield of 5.4%. Earnings per share are predicted to shrink by 7% this year.

Rupert Hargreaves owns shares of GlaxoSmithKline. The Motley Fool UK has recommended Centrica and GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Lloyds shares just dipped below the £1 mark!

Lloyds shares are trading for pennies again! But is this a golden opportunity to pick up shares in the FTSE…

Read more »

ISA coins
Investing Articles

£10,000 put in a Cash ISA a decade ago is now worth…

What would have made someone the most money over the past 10 years -- a Cash ISA or Stocks and…

Read more »

A man with Down's syndrome serves a customer a pint of beer in a pub.
Investing Articles

Are Diageo shares about to pull a Rolls-Royce?

On many metrics, Diageo shares are looking somewhat similar to Rolls-Royce shares a few years back. Could history repeat itself?

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

1 big question to ask when thinking about what Nvidia stock could be worth

Christopher Ruane likes the look of the Nvidia business. But when it comes to its stock price, he's taking a…

Read more »

Night Takeoff Of The American Space Shuttle
Investing Articles

How has the Scottish Mortgage Investment Trust share price risen 57% in a year?

The Scottish Mortgage share price has soared over the last 12 months. After this kind of gain, investors might be…

Read more »

A young black man makes the symbol of a peace sign with two fingers
Investing Articles

I just bought this magnificent £2 UK growth stock for my Stocks and Shares ISA

Edward Sheldon just bought shares in this fast-growing British company for his Stocks and Shares ISA and he’s excited about…

Read more »

British pound data
Investing Articles

The stock market could plummet says the Bank of England

The Bank of England sees a number of risks on the horizon that could derail the stock market’s recent rally.…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Here’s how a £20,000 Stocks and Shares ISA could one day generate £14,947 of passive income a year

Can a five-figure Stocks and Shares ISA end up producing a five-figure annual passive income? This writer shows how it…

Read more »